C
grade
Trojan horse-inspired vaccine-like nanoparticle with enhanced lubrication and active-passive synergistic anti-inflammation for post-traumatic osteoarthritis treatment.
MOTS-C · Bioactive materials · 2026 · Animal study · Preclinical
The PDMI nanoparticle shows promise in reducing friction and inflammation in a rat model of post-traumatic osteoarthritis, but further research is needed to determine its efficacy in humans.
OARSI score reduced by more than 80% in a 4-week rat PTOA model.